Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma

Toxins (Basel). 2013 Aug 14;5(8):1402-21. doi: 10.3390/toxins5081402.

Abstract

In patients with cutaneous T-cell lymphoma (CTCL) bacterial infections constitute a major clinical problem caused by compromised skin barrier and a progressive immunodeficiency. Indeed, the majority of patients with advanced disease die from infections with bacteria, e.g., Staphylococcus aureus. Bacterial toxins such as staphylococcal enterotoxins (SE) have long been suspected to be involved in the pathogenesis in CTCL. Here, we review links between bacterial infections and CTCL with focus on earlier studies addressing a direct role of SE on malignant T cells and recent data indicating novel indirect mechanisms involving SE- and cytokine-driven cross-talk between malignant- and non-malignant T cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bacterial Infections / complications
  • Bacterial Infections / pathology*
  • Bacterial Toxins / toxicity*
  • Cytokines
  • Disease Progression
  • Drug Resistance, Bacterial
  • Enterotoxins / toxicity
  • Genes, T-Cell Receptor beta
  • Humans
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Lymphoma, T-Cell, Cutaneous / microbiology*
  • Lymphoma, T-Cell, Cutaneous / pathology
  • Morbidity
  • Prevalence
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / microbiology
  • Skin Neoplasms / pathology
  • Staphylococcus aureus / metabolism
  • T-Lymphocytes / pathology

Substances

  • Bacterial Toxins
  • Cytokines
  • Enterotoxins